The Latin America, Middle East and Africa miRNA Tools and Services Market should witness market growth of 21.9% CAGR during the forecast period (2022-2028).
Researchers are concentrating on creating an effective microRNA delivery system in order to address these issues. A new, appealing approach for the targeted distribution of microRNAs is the use of nanoparticle delivery systems. Several formulations based on nanotechnology are used, including naturally occurring EVs, lipid nanoparticles (LNPs) made of organic materials, polyamidoamine (PAMAM), gold, and silica dendrimers.
The rise in cancer cases, the prevalence of chronic diseases, the funding of gene therapy research, and cutting-edge drug development techniques that employ RNAi-based methods are the main factors driving the expansion of the miRNA services and tools business. The high cost of medication development as well as the limited number of available therapeutic choices are additional factors pushing the market share growth for miRNA tools and services, which encourages diagnostic companies to create ground-breaking methods based on miRNAs.
Furthermore, miRNA's preclinical and clinical research applications are expanding as a result of ongoing research and clinical studies. MiRNAs may be very useful as biomarkers for diseases caused by pathogenic, medicines for therapeutic intervention in patient health issues, or drug resistance modulators, according to mounting data.
For Latin American women breast cancer is the top cause of death. In 2018 the region witnessed 59,700 instances of breast cancer in Brazil. Puerto Ricans and Cubans had the greatest death rates, while South and Central Americans had the lowest rates. Approximately half of the breast cancer patients in Latin American nations receive their diagnosis in the III and IV stages of the disease. 15-35% of women from Latin America are diagnosed with the subtype of clinically aggressive breast cancer, triple negative breast cancer (TNBC).
The Brazil market dominated the LAMEA miRNA Tools and Services Market by Country in 2021; thereby, achieving a market value of $16.5 million by 2028. The Argentina market is showcasing a CAGR of 22.5% during (2022-2028). Additionally, The UAE market would register a CAGR of 21.6% during (2022-2028).
Based on Technology, the market is segmented into qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools and Others. Based on End-user, the market is segmented into Research & Academic Institutes, IVD, Pharma & Biotech Companies and CROs. Based on Product & Services, the market is segmented into Research Tools and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., New England BioLabs, Inc., Promega Corporation, GeneCopoeia and Norgen Biotek Corp.
Researchers are concentrating on creating an effective microRNA delivery system in order to address these issues. A new, appealing approach for the targeted distribution of microRNAs is the use of nanoparticle delivery systems. Several formulations based on nanotechnology are used, including naturally occurring EVs, lipid nanoparticles (LNPs) made of organic materials, polyamidoamine (PAMAM), gold, and silica dendrimers.
The rise in cancer cases, the prevalence of chronic diseases, the funding of gene therapy research, and cutting-edge drug development techniques that employ RNAi-based methods are the main factors driving the expansion of the miRNA services and tools business. The high cost of medication development as well as the limited number of available therapeutic choices are additional factors pushing the market share growth for miRNA tools and services, which encourages diagnostic companies to create ground-breaking methods based on miRNAs.
Furthermore, miRNA's preclinical and clinical research applications are expanding as a result of ongoing research and clinical studies. MiRNAs may be very useful as biomarkers for diseases caused by pathogenic, medicines for therapeutic intervention in patient health issues, or drug resistance modulators, according to mounting data.
For Latin American women breast cancer is the top cause of death. In 2018 the region witnessed 59,700 instances of breast cancer in Brazil. Puerto Ricans and Cubans had the greatest death rates, while South and Central Americans had the lowest rates. Approximately half of the breast cancer patients in Latin American nations receive their diagnosis in the III and IV stages of the disease. 15-35% of women from Latin America are diagnosed with the subtype of clinically aggressive breast cancer, triple negative breast cancer (TNBC).
The Brazil market dominated the LAMEA miRNA Tools and Services Market by Country in 2021; thereby, achieving a market value of $16.5 million by 2028. The Argentina market is showcasing a CAGR of 22.5% during (2022-2028). Additionally, The UAE market would register a CAGR of 21.6% during (2022-2028).
Based on Technology, the market is segmented into qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools and Others. Based on End-user, the market is segmented into Research & Academic Institutes, IVD, Pharma & Biotech Companies and CROs. Based on Product & Services, the market is segmented into Research Tools and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., New England BioLabs, Inc., Promega Corporation, GeneCopoeia and Norgen Biotek Corp.
Scope of the Study
By Technology
- qRT-PCR
- Extraction Tools
- NGS
- Microarray
- Functional Analysis Tools
- Others
By End-user
- Research & Academic Institutes
- IVD, Pharma & Biotech Companies
- CROs
By Product & Services
- Research Tools
- Services
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Qiagen N.V.
- New England BioLabs, Inc.
- Promega Corporation
- GeneCopoeia
- Norgen Biotek Corp.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA miRNA Tools and Services Market by Technology
Chapter 4. LAMEA miRNA Tools and Services Market by End-user
Chapter 5. LAMEA miRNA Tools and Services Market by Product & Services
Chapter 6. LAMEA miRNA Tools and Services Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- General Electric (GE) Co.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Qiagen N.V.
- New England BioLabs, Inc.
- Promega Corporation
- GeneCopoeia
- Norgen Biotek Corp.
Methodology
LOADING...
